Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Influence of publication of US and European prostate cancer screening trials on PSA testing practices.

Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin DW.

J Natl Cancer Inst. 2011 Mar 16;103(6):520-3. doi: 10.1093/jnci/djr007. Epub 2011 Feb 28.

PMID:
21357307
2.

Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

Vutuc C, Schernhammer ES, Haidinger G, Waldhör T.

Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61.

PMID:
16091872
3.

The science and art of prostate cancer screening.

Yao SL, Lu-Yao GL.

J Natl Cancer Inst. 2011 Mar 16;103(6):450-1. doi: 10.1093/jnci/djr047. Epub 2011 Feb 24. No abstract available.

PMID:
21350220
4.

[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].

Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.

Prog Urol. 2009 Jul;19(7):487-98. doi: 10.1016/j.purol.2009.03.001. Epub 2009 Apr 28. French.

PMID:
19559380
5.

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

Welch HG, Schwartz LM, Woloshin S.

J Natl Cancer Inst. 2005 Aug 3;97(15):1132-7.

PMID:
16077071
6.

Use of prostate-specific antigen for prostate cancer screening in primary care practice.

Williams RB, Boles M, Johnson RE.

Arch Fam Med. 1995 Apr;4(4):311-5.

PMID:
7536091
7.
8.
9.

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I.

Am J Med. 1998 Jun;104(6):517-25.

PMID:
9674713
10.
11.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
12.

The prostate cancer pseudo-epidemic.

Adami HO.

Acta Oncol. 2010 Apr;49(3):298-304. doi: 10.3109/02841860903584945.

PMID:
20397765
13.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
14.

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB.

Arch Intern Med. 1996 Jun 24;156(12):1333-6.

PMID:
8651843
15.

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Mar 16;97(6):433-8.

PMID:
15770007
16.

Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.

D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH.

J Natl Cancer Inst. 2004 Apr 7;96(7):509-15.

PMID:
15069112
17.

Screening for prostate cancer: updated experience from the Tyrol study.

Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P, Bartsch G.

Can J Urol. 2005 Feb;12 Suppl 1:7-13; discussion 92-3.

PMID:
15780158
18.

The effectiveness of screening for prostate cancer: a nested case-control study.

Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, Froehlich G, Blake D, Vickers MA, Gehr GA, Raheb NH, Sullivan G, Peduzzi P.

Arch Intern Med. 2006 Jan 9;166(1):38-43.

PMID:
16401808
19.

Prostate-specific antigen velocity and prostate cancer gleason grade and stage.

Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK.

Cancer. 2007 Apr 15;109(8):1689-95.

20.

Prostate-specific antigen testing practices and outcomes.

Hoffman RM, Blume P, Gilliland F.

J Gen Intern Med. 1998 Feb;13(2):106-10.

Supplemental Content

Support Center